Bumper Offer - Urjas oil Just @ Rs. 1
Fibator Ls is a prescription medicine that is available as a Tablet. Other than this, Fibator Ls has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Fibator Ls. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Fibator Ls have been listed ahead. Usually, these side effects of Fibator Ls go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Fibator Ls has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Fibator Ls's effects on the liver, heart and kidney, if any, have been listed below.
Fibator Ls is not recommended if you suffer from certain medical conditions as it can have adverse effects. Allergy, Kidney Disease, Liver Disease are examples of such conditions.
Drug reaction of Fibator Ls with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Fibator Ls is considered safe while driving, and is addictive.
Fibator Ls is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Fibator Ls is used -
Severe
Is the use of Fibator Ls safe for pregnant women?
Fibator LS may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Fibator LS again without your doctor's advice.
Is the use of Fibator Ls safe during breastfeeding?
Fibator LS may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Fibator LS, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Fibator LS.
What is the effect of Fibator Ls on the Kidneys?
Kidney can be affected by Fibator LS. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Fibator Ls on the Liver?
Very few cases of side effects of Fibator LS on the liver have been reported.
What is the effect of Fibator Ls on the Heart?
Side effects of Fibator LS on heart are unknown because research on this has not been conducted yet.
Fibator Ls should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Fibator Ls unless your doctor advises you to do so -
Is this Fibator Ls habit forming or addictive?
Fibator Ls does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Fibator Ls as it does not make you drowsy.
Is it safe?
Yes, but consume Fibator Ls only on doctor's advice.
Is it able to treat mental disorders?
No, Fibator Ls cannot treat any kind of mental disorder.
Interaction between Food and Fibator Ls
You can take Fibator Ls with food.
Interaction between Alcohol and Fibator Ls
Taking Fibator Ls with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
